. Cost-effectiveness analysis of donepezil and rivastigmine for mild to moderate Alzheimer's disease in Taiwan. Value Health. 2013 May;16(3):A104. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.